Status:
COMPLETED
Endometrial Ablation With Non-hysteroscopic Methods
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Dysfunctional Uterine Bleeding
Eligibility:
FEMALE
30-49 years
Phase:
PHASE4
Brief Summary
Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates ...
Eligibility Criteria
Inclusion
- Women presenting with dysfunctional uterine bleeding having completed their family planning(no wish for further childbearing)
Exclusion
- Endometrial pathology
- FSH \> 20 day 2 -day 3 of the cycle
- Clotting Disorders
- Thyroid Dysfunction
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01173965
Start Date
January 1 2008
End Date
February 1 2011
Last Update
July 12 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
First Dept. Of ObGyn, Medical School Aristotle University of Thessaloniki, Papageorgiou Hospital
Thessaloniki, Thessaloniki, Greece, 56403
2
First Dept. of ObGyn, Medical School, Aristotle University of Thessaloniki, Papageorgiou Hospital
Thessaloniki, Thessaloniki, Greece, 56403